Rad59 Inhibitors

Rad59 inhibitors are classified based on the specific cellular processes they interfere with, and this classification delineates the way they modulate Rad59 function. For instance, Olaparib inhibits PARP and affects Rad59's role in homologous recombination by halting single-strand break repair. Etoposide and Camptothecin are topoisomerase inhibitors that target DNA unwinding and decatenation, thereby interfering with Rad59-facilitated DNA strand exchange and repair. Chemicals like 5-Fluorouracil manipulate the nucleotide pool, affecting DNA integrity and subsequently altering Rad59's DNA repair mechanisms. Such inhibitors act by creating unfavorable conditions for Rad59's function, whether by directly obstructing its role or by stalling associated biochemical pathways.

On the other hand, kinase inhibitors like AZD7762, KU-55933, VX-680, and NU7441 specifically target checkpoint kinases, ATM, Aurora kinases, and DNA-PK, respectively. These inhibitors compromise Rad59's role in cell cycle regulation, DNA damage sensing, chromosomal segregation, and the choice between different DNA repair pathways. RAD51 inhibitor B02 further narrows down the inhibition profile by targeting specific components of the DNA damage repair machinery that interact directly or indirectly with Rad59. For instance, B02 inhibits RAD51 nucleoprotein filament formation, a step crucial for Rad59's role in strand exchange. ATRi, on the other hand, affects the ATR-CHK1 signaling pathway, inhibiting Rad59's role in DNA damage recognition and repair. Overall, these inhibitors act at multiple points in various pathways to effectively modulate the functional role of Rad59.